在乳腺瘤球状体中,β-lapachone 损害了活力,迁移和上皮-介质细胞过渡
Laura Lacerda Coelho1,2, Matheus Menezes Vianna1,2, Debora Moraes da Silva1,2
1Laboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil.
BMC cancer
|November 27, 2025
概括
自然化合物β-lapachone (β-lap) 显示出作为乳腺癌的抗癌药物具有前途. 它有效地减少了瘤球形尺寸,并抑制了3D培养中的细胞活力和迁移.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 乳腺癌是全球女性的主要癌症,转移严重影响预后.
- 天然的纳夫托金β-lapachone (β-lap) 对各种固体瘤具有抗瘤特性.
- 与二维模型相比,三维 (3D) 培养模型在体外更准确地表示瘤结构和药物反应.
研究的目的:
- 用3D培养系统评估β-lapachone (β-lap) 在乳腺瘤球体中的抗癌潜力.
- 研究β-lap对乳腺癌细胞的细胞毒性和抗转移作用.
- 分析β-lap对细胞活力,死亡和上皮层-介质细胞转换 (EMT) 标记物的影响.
主要方法:
- 使用无脚手架的3D培养系统生成了MCF-7乳腺癌球体.
- 细胞毒性影响通过测量球状体直径,细胞死亡和活力来评估.
- 通过分析参与上皮层-介质细胞过渡 (EMT) 的蛋白质,特别是E-cadherin和vimentin,评估了抗转移性质.
主要成果:
- 在72小时内,β-lapachone (β-lap) 显著降低了球状体直径并诱导了1.2 mg/L的细胞死亡.
- 观察到细胞活力的剂量依赖性下降,在较高度 (5-10 mg/L) 时降低高达50%.
- β-lap抑制了细胞迁移和调节EMT,使E-cadherin增加了18.4%,而维门丁减少了34.3%.
结论:
- 自然化合物β-lapachone (β-lap) 显示出作为乳腺癌的抗癌疗法具有显著的潜力.
- 它在3D模型中抑制瘤生长,降低活力和抑制转移的能力需要进一步调查.
- β-lap是开发新型乳腺癌治疗策略的有前途的天然药物.
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Cell Migration through Invadopodia
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Cell Motility through Blebbing
Blebs are a type of membrane protrusion formed by the internal hydrostatic pressure of the cytoplasm. Blebs are observed in several cell types, including fibroblasts, immune cells, and single-celled organisms like the amoeba. The primary function of blebs is cell locomotion and apoptosis, but they are also found during necrosis and cell division. The life cycle of a bleb comprises an initiation phase followed by the expansion and retraction phases.
Blebbing Through the Matrix
In multicellular...
Blebbing Through the Matrix
In multicellular...
The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Tissue-Drug Binding: Localization of Drugs and its Significance
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine the...
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine the...


